Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 24073316)

1.

What Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot Study.

Kawamura Y, Ikeda K, Fukushima T, Seko Y, Hara T, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H.

Gut Liver. 2013 Sep;7(5):576-84. doi: 10.5009/gnl.2013.7.5.576. Epub 2013 Aug 14.

2.

Radiofrequency ablation combined with chemolipiodolization in a porcine liver: Comparison of the pharmacokinetic analysis with cisplatin powder and miriplatin.

Ito T, Okubo H, Kokubu S, Miyazaki A, Ando H, Fujimura A, Watanabe S.

Hepatol Res. 2015 May;45(5):589-94. doi: 10.1111/hepr.12387. Epub 2014 Jul 28.

PMID:
25040841
3.

A comparison of Re-188-MN-16ET-lipiodol and transcatheter arterial chemoembolization in the treatment of hepatoma: an animal study.

Lin WY, Luo TY, Tsai SC, Kao CH, Tang IC, Huang PW.

Nucl Med Biol. 2013 Apr;40(3):437-41. doi: 10.1016/j.nucmedbio.2012.11.007. Epub 2013 Jan 23.

PMID:
23352603
4.

Clinical utility of transarterial infusion chemotherapy using cisplatin-lipiodol emulsion for unresectable hepatocellular carcinoma.

Beppu T, Sugimoto K, Shiraki K, Tameda M, Inagaki Y, Ogura S, Kasai C, Kusagawa S, Nojiri K, Yoneda M, Fuke H, Yamamoto N, Takei Y, Fujimori M, Hasegawa T, Yamanaka T, Uraki J, Kashima M, Takaki H, Nakatsuka A, Yamakado K, Takeda K.

Anticancer Res. 2012 Nov;32(11):4923-30.

PMID:
23155261
5.

Short-term therapeutic effects of transcatheter arterial chemoembolization using miriplatin-lipiodol suspension for hepatocellular carcinoma.

Oguro S, Hashimoto S, Tanaka T, Inoue M, Nakatsuka S, Kuribayashi S, Asakura K, Kawachi S, Tanabe M, Kitagawa Y, Ebinuma H, Saito H, Hibi T.

Jpn J Radiol. 2012 Nov;30(9):735-42. doi: 10.1007/s11604-012-0116-1. Epub 2012 Aug 28.

PMID:
22923183
6.

Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence.

Nishikawa H, Osaki Y, Kita R, Kimura T, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Saito S, Nasu A.

Int J Oncol. 2012 Sep;41(3):903-9. doi: 10.3892/ijo.2012.1512. Epub 2012 Jun 11.

PMID:
22692851
7.

Nitroglycerine use in transcatheter arterial (chemo)embolization in patients with hepatocellular carcinoma and dual-energy CT assessment of Lipiodol retention.

Liu YS, Chuang MT, Tsai YS, Tsai HM, Lin XZ.

Eur Radiol. 2012 Oct;22(10):2193-200. doi: 10.1007/s00330-012-2484-4. Epub 2012 May 24.

PMID:
22618520
8.
9.

Effect of transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma.

Yamasaki T, Saeki I, Harima Y, Zaitsu J, Maeda M, Tanimoto H, Iwamoto T, Hidaka I, Urata Y, Ishikawa T, Takami T, Yamaguchi Y, Uchida K, Terai S, Sakaida I.

J Gastroenterol. 2012 Jun;47(6):715-22. doi: 10.1007/s00535-012-0537-8. Epub 2012 Feb 11.

PMID:
22322658
10.

Hepatic intra-arterial cetuximab in combination with 5-fluorouracil and cisplatin as salvage treatment for sorafenib-refractory hepatocellular carcinoma.

Poggi G, Montagna B, Melchiorre F, Quaretti P, Delmonte A, Riccardi A, Tagliaferri B, Sottotetti F, Di Cesare P, Stella MG, Villani L, Zorzetto M, Greco G, Cornalba G, Bernardo G.

Anticancer Res. 2011 Nov;31(11):3927-33.

PMID:
22110221
11.

Evaluation of a bioresorbable drug delivery system for the treatment of hepatocellular carcinoma.

Vedantham K, Swet JH, McKillop IH, El-Ghannam A.

J Biomed Mater Res A. 2012 Feb;100(2):432-40. doi: 10.1002/jbm.a.33228. Epub 2011 Nov 21.

PMID:
22105845
12.
13.
14.

Transcatheter arterial chemoembolization with fine-powder cisplatin-lipiodol for HCC.

Koizumi Y, Hirooka M, Uehara T, Kisaka Y, Uesugi K, Kumagi T, Abe M, Matsuura B, Hiasa Y, Onji M.

Hepatogastroenterology. 2011 Mar-Apr;58(106):512-5.

PMID:
21661422
15.

Prevention of intrahepatic distant recurrence by transcatheter arterial infusion chemotherapy with platinum agents for stage I/II hepatocellular carcinoma.

Ishikawa T, Higuchi K, Kubota T, Seki K, Honma T, Yoshida T, Kamimura T.

Cancer. 2011 Sep 1;117(17):4018-25. doi: 10.1002/cncr.25989. Epub 2011 Mar 1.

17.

[Efficacy of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma].

Usui T, Shiozawa S, Kim DH, Tsuchiya A, Masuda T, Inose S, Aizawa M, Yoshimatsu K, Katsube T, Naritaka Y, Ogawa K.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2702-4. Japanese.

PMID:
21224685
18.

Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.

Maeda N, Osuga K, Higashihara H, Tomoda K, Mikami K, Nakazawa T, Nakamura H, Tomiyama N.

Cardiovasc Intervent Radiol. 2012 Feb;35(1):82-9. doi: 10.1007/s00270-010-0086-6. Epub 2011 Jan 4.

PMID:
21203761
19.

Hypersensitivity reactions to transcatheter chemoembolization with cisplatin and Lipiodol suspension for unresectable hepatocellular carcinoma.

Kawaoka T, Aikata H, Katamura Y, Takaki S, Waki K, Hiramatsu A, Takahashi S, Hieda M, Kakizawa H, Chayama K.

J Vasc Interv Radiol. 2010 Aug;21(8):1219-25. doi: 10.1016/j.jvir.2010.04.014.

PMID:
20619676
20.

Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma.

Sahara S, Kawai N, Sato M, Minamiguchi H, Nakai M, Takasaka I, Nakata K, Ikoma A, Sawa N, Sonomura T, Shirai S.

Jpn J Radiol. 2010 Jun;28(5):362-8. doi: 10.1007/s11604-010-0436-y. Epub 2010 Jun 30.

PMID:
20585924
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk